Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Queensland Health
Boehringer Ingelheim
Chinese Patent Office
QuintilesIMS
Chubb
Deloitte
AstraZeneca
Fuji

Generated: April 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017434

« Back to Dashboard

NDA 017434 describes PROSTIN F2 ALPHA, which is a drug marketed by Pharmacia And Upjohn and is included in one NDA. Additional details are available on the PROSTIN F2 ALPHA profile page.

The generic ingredient in PROSTIN F2 ALPHA is dinoprost tromethamine. There are six drug master file entries for this compound. Additional details are available on the dinoprost tromethamine profile page.
Summary for 017434
Tradename:PROSTIN F2 ALPHA
Applicant:Pharmacia And Upjohn
Ingredient:dinoprost tromethamine
Patents:0
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 017434

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrengthEQ 5MG BASE/ML
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Expired US Patents for NDA 017434

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pharmacia And Upjohn PROSTIN F2 ALPHA dinoprost tromethamine INJECTABLE;INJECTION 017434-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Pharmacia And Upjohn PROSTIN F2 ALPHA dinoprost tromethamine INJECTABLE;INJECTION 017434-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Pharmacia And Upjohn PROSTIN F2 ALPHA dinoprost tromethamine INJECTABLE;INJECTION 017434-001 Approved Prior to Jan 1, 1982 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Teva
Queensland Health
McKinsey
McKesson
Cerilliant
Medtronic
Argus Health
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.